: Granulysin is a cytolytic molecule expressed by CTL and NK cells with activity against a variety of microbes and tumors. We first identified granulysin as part of a search for genes expressed by T lymphocytes """"""""late"""""""" (3-5 days) after T cell activation. Over the first four years of this grant, we described the biosynthesis of granulysin, generated granulysin specific monoclonal antibodies, and characterized the cytolytic and antimicrobial activities of granulysin. In this renewal application, we propose to further define the mechanism of action and in vivo function of granulysin. Specifically, we will further elucidate the molecular pathways involved in granulysin mediated apoptosis; express human granulysin in murine T cells using both transgenic and retroviral technologies, and evaluate the therapeutic efficacy of synthetic peptides corresponding to sub regions of granulysin in vivo. The effects of granulysin or granulysin peptides will be assessed against both microbial and tumor targets. The ultimate goal of these studies is to use granulysin, peptide components, and/or the information gained from the mechanistic studies to develop new antibiotics and/or tumor chemotherapeutic agents.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI043348-08
Application #
7073425
Study Section
Experimental Immunology Study Section (EI)
Program Officer
Miller, Lara R
Project Start
1998-07-01
Project End
2007-11-30
Budget Start
2006-06-01
Budget End
2007-11-30
Support Year
8
Fiscal Year
2006
Total Cost
$308,584
Indirect Cost
Name
Stanford University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
da Silva, Ana Paula Galvao; Unks, Donovan; Lyu, Shu-chen et al. (2008) In vitro and in vivo antimicrobial activity of granulysin-derived peptides against Vibrio cholerae. J Antimicrob Chemother 61:1103-9
Li, Q; Morimoto, K; Kobayashi, M et al. (2008) Visiting a forest, but not a city, increases human natural killer activity and expression of anti-cancer proteins. Int J Immunopathol Pharmacol 21:117-27
Wu, Bo; Huang, Chunhong; Kato-Maeda, Midori et al. (2008) IL-24 modulates IFN-gamma expression in patients with tuberculosis. Immunol Lett 117:57-62
Di Liberto, Diana; Buccheri, Simona; Caccamo, Nadia et al. (2007) Decreased serum granulysin levels in childhood tuberculosis which reverse after therapy. Tuberculosis (Edinb) 87:322-8
Chen, Xi; Howe, Jorg; Andra, Jorg et al. (2007) Biophysical analysis of the interaction of granulysin-derived peptides with enterobacterial endotoxins. Biochim Biophys Acta 1768:2421-31
Li, Q; Morimoto, K; Nakadai, A et al. (2007) Forest bathing enhances human natural killer activity and expression of anti-cancer proteins. Int J Immunopathol Pharmacol 20:3-8
Huang, Lisa P; Lyu, Shu-Chen; Clayberger, Carol et al. (2007) Granulysin-mediated tumor rejection in transgenic mice. J Immunol 178:77-84
Li, Qing; Morimoto, Kanehisa; Nakadai, Ari et al. (2007) Healthy lifestyles are associated with higher levels of perforin, granulysin and granzymes A/B-expressing cells in peripheral blood lymphocytes. Prev Med 44:117-23
Li, Qing; Dong, Chen; Deng, Anmei et al. (2005) Hemolysis of erythrocytes by granulysin-derived peptides but not by granulysin. Antimicrob Agents Chemother 49:388-97
Krensky, Alan M; Clayberger, Carol (2005) Granulysin: a novel host defense molecule. Am J Transplant 5:1789-92